Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Digest of Vermont.
Press releases published on July 16, 2025
Avocado Green Mattress Launches Its First-Ever Wool Mattress — A Latex-Free Innerspring Built for Breathability, Comfort, and Sustainable Living
GlobeNewswire
·
July 16, 2025
Los Angeles, CA, July 16, 2025 (GLOBE NEWSWIRE) -- Unlike most natural and organic mattresses, the Avocado Wool Mattress contains no latex whatsoever. Instead, it features a meticulously crafted construction of certified organic wool layered over more than …
Teladoc Health to Announce Second Quarter 2025 Financial Results
GlobeNewswire
·
July 16, 2025
NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in virtual care, announced that it will release second quarter 2025 results on Tuesday, July 29, 2025, after the market closes. In conjunction, the company will …
BriaCell Therapeutics Announces Closing of $15 million Public Offering
GlobeNewswire
·
July 16, 2025
PHILADELPHIA and VANCOUVER, British Columbia, July 16, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to …
Senseonics Holdings, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call for August 6, 2025 at 4:30 P.M. Eastern Time
GlobeNewswire
·
July 16, 2025
GERMANTOWN, Md., July 16, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people …
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
July 16, 2025
CONSHOHOCKEN, Pa., July 16, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it …
Vincerx Pharma, Inc. Announces Additional Adjournment of Special Meeting - Urges Stockholders to Vote FOR Approval of Dissolution Proposal
GlobeNewswire
·
July 16, 2025
Revised Potential Distribution Range of $0.03 to $0.07 per share based on current estimates and assumptions Failure to approve Dissolution Proposal on a timely basis will result in continued operating costs and further reduce or eliminate any potential …
Outset Medical to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025
GlobeNewswire
·
July 16, 2025
SAN JOSE, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release …
Anika to Issue Second Quarter 2025 Financial Results on Wednesday, July 30, 2025
GlobeNewswire
·
July 16, 2025
BEDFORD, Mass., July 16, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue its second quarter 2025 financial results before the …
60 Degrees Pharmaceuticals Announces Closing of up to $10 Million Public Offering
GlobeNewswire
·
July 16, 2025
WASHINGTON, July 16, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (the “Company” or “60 Degrees”) (Nasdaq: SXTP; SXTPW), a pharmaceutical company focused on developing new medicines for infectious diseases, today announced the closing of its …
Female Muscle Growth: How CrazyBulk’s Natural Legal Steroids Are Reshaping Muscle Building Supplements For Bodybuilding Women
GlobeNewswire
·
July 16, 2025
New York City, NY, July 16, 2025 (GLOBE NEWSWIRE) -- In a year where health, performance, and gender inclusivity are taking center stage, female muscle growth is no longer a fringe topic—it’s a global movement. Leading this transformation is CrazyBulk, …
Quetzal Therapeutics Debuts with Expert Leadership, High-Impact Pipeline and $50 Million of Committed Capital
GlobeNewswire
·
July 16, 2025
CHICAGO, July 16, 2025 (GLOBE NEWSWIRE) -- Quetzal Therapeutics, a newly formed biopharmaceutical company, announced its official launch today with $50 million of committed capital. Founded to address urgent unmet needs in rare and life-threatening …
Obstructive Sleep Apnea Clinical Trial Pipeline Expands as 12+ Companies Driving Innovation in OSA Therapeutics | DelveInsight
GlobeNewswire
·
July 16, 2025
New York, USA, July 16, 2025 (GLOBE NEWSWIRE) -- Obstructive Sleep Apnea Clinical Trial Pipeline Expands as 12+ Companies Driving Innovation in OSA Therapeutics | DelveInsight The obstructive sleep apnea (OSA) market is being propelled by the rapid …
Constant Therapy Announces Collaboration with Burke Rehabilitation to Offer NY's First AI-Driven Post-Acute Outpatient Speech Therapy
GlobeNewswire
·
July 16, 2025
LEXINGTON, Mass., July 16, 2025 (GLOBE NEWSWIRE) -- Constant Therapy today announced a first-in-state collaboration with New York-based Burke Rehabilitation to launch an AI-powered post-acute speech therapy program for patients with stroke, brain injuries, …
Tevogen.AI Targets Faster Time-to-Market with AI-Powered Patient Matching Following PredicTcell™ Alpha Launch
GlobeNewswire
·
July 16, 2025
Advanced algorithms aim to reduce trial planning timelines, accelerating time-to-market for new therapies Initiative to support Tevogen Bio’s ExacTcell™ pipeline with a goal of enhancing commercial viability and shareholder value WARREN, N.J., July 16, …
eMI Aesthetics Announces Launch of AI-Powered Aesthetic Simulation Platform for Cosmetic Treatment Visualization
GlobeNewswire
·
July 16, 2025
Miami, FL, July 16, 2025 (GLOBE NEWSWIRE) -- eMI Aesthetics, a leader in AI-driven cosmetic imaging, today announced the launch of its AI-powered aesthetic simulation platform for cosmetic treatment visualization. With over 100,000 users, eMI Aesthetics' …
Aesthetic Business Strategist Dr. Kalpana Sundar to Host Transformational Profit Accelerator Bootcamp for Medspa Owners in Albuquerque – August 7–10, 2025
GlobeNewswire
·
July 16, 2025
ALBUQUERQUE, New Mexico, July 16, 2025 (GLOBE NEWSWIRE) -- As the medical aesthetics industry continues to experience exponential growth, many medspa owners and aesthetic providers find themselves overwhelmed — juggling clients, marketing, operations, and …
A Statement from the Global Virus Network (GVN) on the Rapidly Escalating Measles Crisis in the U.S. and Worldwide
GlobeNewswire
·
July 16, 2025
TAMPA, Fla., July 16, 2025 (GLOBE NEWSWIRE) -- The Global Virus Network (GVN), a coalition of leading human and animal virologists from 80+ Centers of Excellence and Affiliates in more than 40 countries, is sounding the alarm over a sharp resurgence of …
Dallas Business Journal Recognizes U.S. Oral Surgery Management for Continued Growth
GlobeNewswire
·
July 16, 2025
IRVING, Texas, July 16, 2025 (GLOBE NEWSWIRE) -- For the second year in a row, the Dallas Business Journal has named Irving’s U.S. Oral Surgery Management (USOSM) to this year’s Fast 50 – a list of the 50 fastest growing companies in the Dallas-Fort Worth …
Windtree To Launch BNB Crypto Treasury Strategy With Agreement For $60 Million Investment Led By Build And Build Corp. With Up To $140 Million More In Follow On Subscriptions
GlobeNewswire
·
July 16, 2025
WARRINGTON, Pa., July 16, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT) is excited to announce it has entered into a $60 million securities purchase agreement led by Build and Build Corp, with the …
OKYO Pharma Unveils Strong Phase 2 Clinical Trial Results for Urcosimod to Treat Neuropathic Corneal Pain
GlobeNewswire
·
July 16, 2025
After 12 weeks of treatment, 75% of per-protocol patients receiving 0.05% urcosimod showed greater than 80% reduction in neuropathic corneal pain (NCP), as measured by Visual Analogue Scale (VAS), demonstrating highly effective treatment. Urcosimod (0.05%) …